ORPEA Announces the First Drawdown of 250 Million Euros Under the Financing Agreement With Its Core Banking Pool
ORPEA has completed the necessary conditions for its financing agreements and has drawn down €250 million following the protocol announced on June 13, 2022. The drawn funds will be utilized for various corporate purposes, including debt service and capital expenditures. The company continues to execute the financing agreement as planned and will keep the market informed about the next steps in compliance with regulatory obligations. ORPEA is a leader in dependency care and is listed on Euronext Paris.
- Successfully drew down €250 million to support corporate financing needs.
- Continues with planned execution of financing agreements.
- None.
Following the completion of the conditions precedent provided for in the financing agreements and the conciliation protocol announced on
The drawn funds will be used to finance and refinance general corporate purposes of the Group (including, but not limited to, debt service and capital expenditures) as well as the fees owed under the Financing Agreement.
The Company is therefore continuing with the execution of the financing agreement as envisaged and will continue to inform the market on the next steps of its implementation, in compliance with its legal and regulatory obligations.
About
Founded in 1989,
View source version on businesswire.com: https://www.businesswire.com/news/home/20220615006046/en/
Investor Relations
Investor Relations Director
b.lesieur@orpea.net
Investor Relations
NewCap
Dusan Oresansky
Tel. : +331 44 71 94 94
ORPEA@newcap.eu
Media Relations
Image 7
Tel.: +33 (0)6 78 37 27 60
clebarbier@image7.fr
Tel. : 06 89 87 61 24
Caroline.simon@image7.fr
Source:
FAQ
What is the significance of ORPEA's €250 million drawdown?
When was the financing agreement protocol announced for ORPEA?
What will ORPEA use the drawn funds for?
Is ORPEA continuing to implement its financing agreements?